The DOI matches its Crossref record.
Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src.
Open accessAbstract
We have previously found that Rous sarcoma virus variants in which the viral src (v-src) gene is replaced by the cellular src (c-src) gene have no transforming activity. In this study, we analyzed the basis for the inability of the p60c-src overproduced by these variants to transform cells. Phosphorylations of tyrosine residues in total cell protein or in cellular 34K protein are known to be markedly enhanced upon infection with wild-type Rous sarcoma virus. We found that these tyrosine phosphorylations were only slightly increased in the c-src-containing virus-infected cells, whereas both levels were significantly increased by infection with wild-type Rous sarcoma virus, or transforming mutant viruses which are derived from c-src-containing viruses by spontaneous mutation. Phosphorylation at tyrosine 416 of p60 itself was also extremely low in overproduced p60c-src and high in p60s of transforming mutant viruses. In immunoprecipitates with monoclonal antibody, the overproduced p60c-src had much lower casein tyrosine kinase activity than did p60v-src. We previously showed that p60 myristylation and plasma membrane localization may be required for cell transformation. p60c-src was similar to transforming p60s in these properties. These results strongly suggest that the low level of tyrosine phosphorylation by overproduced p60c-src accounts for its inability to transform cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,172
The Action of Oncogenes in the Cytoplasm and Nucleus
Weinberg, R. A. (1985) · Science · doi:10.1126/science.2997917 · Cited by 689
Kmiecik, T. E., & Shalloway, D. (1987) · Cell · doi:10.1016/0092-8674(87)90756-2 · Cited by 623
Tyr 527 Is Phosphorylated in pp60 c- src : Implications for Regulation
Cooper, J. A., Gould, K. L., Cartwright, C. A., & Hunter, T. (1986) · Science · doi:10.1126/science.2420005 · Cited by 540
Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src
Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., & Cheng, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90757-4 · Cited by 520
Mustelin, T., Coggeshall, K. M., & Altman, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6302 · Cited by 422
Imamoto, A., & Soriano, P. (1993) · Cell · doi:10.1016/0092-8674(93)90641-3 · Cited by 396
Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain
Cartwright, C. A., Eckhart, W., Simon, S., & Kaplan, P. L. (1987) · Cell · doi:10.1016/0092-8674(87)90758-6 · Cited by 390
Neurones express high levels of a structurally modified, activated form of pp60c-src
Brugge, J. S., Cotton, P. C., Queral, A. E., Barrett, J. N., Nonner, D., & Keane, R. W. (1985) · Nature · doi:10.1038/316554a0 · Cited by 360
[28] Use and specificity of staurosporine, UCN-O1, and calphostin C as protein kinase inhibitors
Tamaoki, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01030-6 · Cited by 330
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor)
Roussel, M. F., Dull, T. J., Rettenmier, C. W., Ralph, P., Ullrich, A., & Sherr, C. J. (1987) · Nature · doi:10.1038/325549a0 · Cited by 324
Regulation of Btk Function by a Major Autophosphorylation Site Within the SH3 Domain
Park, H., Wahl, M. I., Afar, D. E. H., Turck, C. W., Rawlings, D. J., Tam, C., Scharenberg, A. M., Kinet, J.-P., & Witte, O. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80417-3 · Cited by 323
Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity.
Golden, A., Nemeth, S. P., & Brugge, J. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.852 · Cited by 316
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
Bargmann, C. I., & Weinberg, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03044.x · Cited by 315
A Protein Tyrosine Kinase Involved in Regulation of pp60c-src function
Okada, M., & Nakagawa, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30019-5 · Cited by 301
Activation of pp60c-src protein kinase activity in human colon carcinoma.
Bolen, J. B., Veillette, A., Schwartz, A. M., DeSeau, V, & Rosen, N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2251 · Cited by 299
Quintrell, N., Lebo, R., Varmus, H., Bishop, J. M., Pettenati, M. J., Le Beau, M. M., Diaz, M. O., & Rowley, J. D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.6.2267 · Cited by 266
pp60c-src activation in human colon carcinoma.
Cartwright, C. A., Kamps, M. P., Meisler, A. I., Pipas, J. M., & Eckhart, W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114113 · Cited by 265
NAKANO, H., KOBAYASHI, E., TAKAHASHI, I., TAMAOKI, T., KUZUU, Y., & IBA, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.706 · Cited by 262
Self-citationDephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.
Cooper, J. A., & King, C. S. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4467 · Cited by 254
Metadata
- Authors
- Iba, H., Cross, F. R., Garber, E. A., & Hanafusa, H.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1985-05
- Volume
- 5
- Issue
- 5
- Pages
- 1058-1066
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1875713186
- Cited by
- 177
- References
- 0
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.